These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 21029629)

  • 1. [Anti-tumor efficacy of interventional chemotherapy with liposomal doxorubicin for hepatic metastasis of pancreatic cancer in nude mouse model].
    Xie YB; Wang Z; Han ZK; Li AD; Zhang ZQ; Li H; Ma J; Zhao P
    Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(30):2126-9. PubMed ID: 21029629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the optimal combination chemotherapy regimen for treatment of platinum-resistant ovarian cancer in nude mouse model.
    Saucier JM; Yu J; Gaikwad A; Coleman RL; Wolf JK; Smith JA
    J Oncol Pharm Pract; 2007 Mar; 13(1):39-45. PubMed ID: 17621566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of metastatic carcinoma cell growth in livers by poly(I):poly(C)/cationic liposome complex (LIC).
    Hirabayashi K; Yano J; Takesue H; Fujiwara N; Irimura T
    Oncol Res; 1999; 11(11-12):497-504. PubMed ID: 10905561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective tumor regression by anti-neovascular therapy in hypovascular orthotopic pancreatic tumor model.
    Yonezawa S; Asai T; Oku N
    J Control Release; 2007 Apr; 118(3):303-9. PubMed ID: 17275944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultrasound enhanced antitumor activity of liposomal doxorubicin in mice.
    Hagtvet E; Evjen TJ; Olsen DR; Fossheim SL; Nilssen EA
    J Drug Target; 2011 Sep; 19(8):701-8. PubMed ID: 21524240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo antitumor effect of cromolyn in PEGylated liposomes for pancreatic cancer.
    Kim CE; Lim SK; Kim JS
    J Control Release; 2012 Jan; 157(2):190-5. PubMed ID: 21963773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Signal therapy of human pancreatic cancer and NF1-deficient breast cancer xenograft in mice by a combination of PP1 and GL-2003, anti-PAK1 drugs (Tyr-kinase inhibitors).
    Hirokawa Y; Levitzki A; Lessene G; Baell J; Xiao Y; Zhu H; Maruta H
    Cancer Lett; 2007 Jan; 245(1-2):242-51. PubMed ID: 16540233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interstitial chemotherapy with ricin-loaded thermosensitive hydrogel in pancreatic cancer xenograft.
    Chen ZK; Lin LW; Weng XH; Xue ES; Lin YH
    Hepatobiliary Pancreat Dis Int; 2009 Aug; 8(4):418-23. PubMed ID: 19666413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release.
    Kong G; Anyarambhatla G; Petros WP; Braun RD; Colvin OM; Needham D; Dewhirst MW
    Cancer Res; 2000 Dec; 60(24):6950-7. PubMed ID: 11156395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
    Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of kigamicin D on mouse tumor models.
    Masuda T; Ohba S; Kawada M; Osono M; Ikeda D; Esumi H; Kunimoto S
    J Antibiot (Tokyo); 2006 Apr; 59(4):209-14. PubMed ID: 16830887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin E enhances anticancer activity of doxorubicin on human prostate cancer cells showing resistance to TRAIL-mediated apoptosis.
    Yasukochi A; Kawakubo T; Nakamura S; Yamamoto K
    Biol Chem; 2010 Aug; 391(8):947-58. PubMed ID: 20482316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A chitosan-dipotassium orthophosphate hydrogel for the delivery of Doxorubicin in the treatment of osteosarcoma.
    Ta HT; Dass CR; Larson I; Choong PF; Dunstan DE
    Biomaterials; 2009 Jul; 30(21):3605-13. PubMed ID: 19345993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
    Zhong Z; Carroll KD; Policarpio D; Osborn C; Gregory M; Bassi R; Jimenez X; Prewett M; Liebisch G; Persaud K; Burtrum D; Wang S; Surguladze D; Ng S; Griffith H; Balderes P; Doody J; Schwartz JD; Youssoufian H; Rowinsky EK; Ludwig DL; Witte L; Zhu Z; Wu Y
    Clin Cancer Res; 2010 Feb; 16(4):1191-205. PubMed ID: 20145179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?
    Hong RL; Huang CJ; Tseng YL; Pang VF; Chen ST; Liu JJ; Chang FH
    Clin Cancer Res; 1999 Nov; 5(11):3645-52. PubMed ID: 10589782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic profile of the microtubule stabilizer patupilone in tumor-bearing rodents and comparison of anti-cancer activity with other MTS in vitro and in vivo.
    O'Reilly T; Wartmann M; Brueggen J; Allegrini PR; Floersheimer A; Maira M; McSheehy PM
    Cancer Chemother Pharmacol; 2008 Nov; 62(6):1045-54. PubMed ID: 18301895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A clinical nude mouse metastatic model for highly malignant human pancreatic cancer.
    An Z; Wang X; Kubota T; Moossa AR; Hoffman RM
    Anticancer Res; 1996; 16(2):627-31. PubMed ID: 8687107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitomycin C and cisplatin increase survival in a human pancreatic cancer metastatic model.
    Tomikawa M; Kubota T; Matsuzaki SW; Takahasi S; Kitajima M; Moosa AR; Hoffman RM
    Anticancer Res; 1997; 17(5A):3623-5. PubMed ID: 9413214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy, biodistribution, and pharmacokinetics of CD22-targeted pegylated liposomal doxorubicin in a B-cell non-Hodgkin's lymphoma xenograft mouse model.
    Tuscano JM; Martin SM; Ma Y; Zamboni W; O'Donnell RT
    Clin Cancer Res; 2010 May; 16(10):2760-8. PubMed ID: 20460479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.